Leigh Zawel serves as Executive at Cullinan Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Leigh Zawel has executed 17 insider transactions totaling $4.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 11, 2022 involved receiving (via award) 32,500 shares valued at $0.
Leigh Zawel currently holds 69,785 shares of Cullinan Oncology, Inc. (CGEM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Leigh Zawel has been a net seller of CGEM stock. They have purchased $0 and sold $4.7M worth of shares.
Leigh Zawel's most recent insider trade was on Feb 11, 2022, when they sold 32,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $25.00 |
| Discretionary |
| Oct 7, 2021 | CGEM | $27.0K | Sale | 1,079 | $25.00 | Discretionary |
| Sep 20, 2021 | CGEM | $187.9K | Sale | 7,468 | $25.16 | Discretionary |
| Sep 7, 2021 | CGEM | $814.0K | Sale | 28,118 | $28.95 | Discretionary |
| Aug 23, 2021 | CGEM | $815.4K | Sale | 28,118 | $29.00 | Discretionary |
| Aug 23, 2021 | CGEM | $815.4K | Sale | 28,118 | $29.00 | Discretionary |
| Aug 10, 2021 | CGEM | $87.2K | Sale | 3,191 | $27.34 | Discretionary |
| Aug 10, 2021 | CGEM | $50.5K | Sale | 1,906 | $26.50 | Discretionary |
| Aug 10, 2021 | CGEM | $51.8K | Sale | 1,817 | $28.49 | Discretionary |
| Aug 10, 2021 | CGEM | $50.5K | Sale | 1,906 | $26.50 | Discretionary |
| Aug 10, 2021 | CGEM | $51.8K | Sale | 1,817 | $28.49 | Discretionary |
| Aug 10, 2021 | CGEM | $87.2K | Sale | 3,191 | $27.34 | Discretionary |
| Aug 9, 2021 | CGEM | $46.1K | Sale | 1,700 | $27.11 | Discretionary |
| Aug 9, 2021 | CGEM | $517.2K | Sale | 19,504 | $26.52 | Discretionary |
| Aug 9, 2021 | CGEM | $517.2K | Sale | 19,504 | $26.52 | Discretionary |
| Aug 9, 2021 | CGEM | $46.1K | Sale | 1,700 | $27.11 | Discretionary |